Ann: Strategic Alliance and Capital Raising, page-2

The BCG Alliance opportunities may include:

1. Assistance by BCG with GTG's utilisation of its existing labs and Genomic Testing Platform to support a USA DNA genomic data Platform utilising the Blockchain to enable rapid collection and dissemination of Genomic data to big pharma, researchers and the general public for personalised medicine and health initiatives.
2. Assist with the development of Blockchain based solutions to tackle the estimated $200B ayear loss by big pharma as a result of drug counterfeiting.
3. Establish a division incorporating a Blockchain accelerator and seed investment arm focussing on new technologies in the Biotech and Medical markets.

It must be emphasised that the non-binding terms sheet provides GTG with a framework to consider
not only these specific blockchain opportunities, but also an ongoing pipeline of potential medical and
biotech related blockchain opportunities.

Awesome